10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 364 filers reported holding 10X GENOMICS INC in Q4 2021. The put-call ratio across all filers is 0.41 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $716,678 | -26.1% | 17,374 | +0.0% | 0.02% | -22.6% |
| Q2 2023 | $969,941 | +0.0% | 17,370 | -0.1% | 0.03% | -6.1% |
| Q1 2023 | $969,574 | +30.5% | 17,379 | -14.8% | 0.03% | +3.1% |
| Q4 2022 | $742,975 | +29.0% | 20,389 | +0.8% | 0.03% | +18.5% |
| Q3 2022 | $576,000 | -36.9% | 20,235 | +0.3% | 0.03% | -35.7% |
| Q2 2022 | $913,000 | -39.6% | 20,166 | -0.3% | 0.04% | -30.0% |
| Q1 2022 | $1,512,000 | +36.7% | 20,234 | +172.5% | 0.06% | +46.3% |
| Q4 2021 | $1,106,000 | +110500.0% | 7,424 | +74140.0% | 0.04% | – |
| Q3 2021 | $1,000 | -50.0% | 10 | -9.1% | 0.00% | – |
| Q2 2021 | $2,000 | -99.7% | 11 | -99.7% | 0.00% | -100.0% |
| Q1 2021 | $630,000 | +20900.0% | 3,480 | +19233.3% | 0.03% | – |
| Q4 2020 | $3,000 | – | 18 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management I, LLC | 750,000 | $111,720,000 | 99.68% |
| Foresite Capital Management II, LLC | 1,753,528 | $261,206,000 | 99.34% |
| Venrock Management VI, LLC | 962,309 | $143,346,000 | 96.17% |
| 12 West Capital Management LP | 2,004,000 | $298,516,000 | 13.24% |
| FINANCIAL CONSULATE, INC | 154,942 | $23,080,000 | 8.00% |
| Meritech Capital Associates V L.L.C. | 1,610,824 | $239,948,000 | 7.68% |
| Andar Capital Management HK Ltd | 55,000 | $8,193,000 | 7.52% |
| JS Capital Management LLC | 540,589 | $80,526,000 | 3.66% |
| HARVARD MANAGEMENT CO INC | 186,143 | $27,728,000 | 2.60% |
| Connective Portfolio Management, LLC | 7,000 | $1,056,000 | 1.86% |